Erratum - Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration

Author(s):  

Issue:  Mar/Apr 2025 - Volume 29, Number 2
View All Articles in Issue

Abstract:  In the article “Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration,” [Reference: Int J Pharm Compd. 2021; 25 (1): 52-61.] Table 1, row 33 states that the challenge drug was “Total Parenteral Nutrition, Hospira (Lot 87-308-DK).” This challenge drug description should be corrected to “TPN Electrolytes, Hospira (Lot 87-308-DK).

Related Categories: STABILITIES, COMPATIBILITIES

Purchase this article for download in electronic PDF format from IJPC at for $75 at:
https://ijpc.com/Abstracts/Abstract.cfm?ABS=5441

Search the entire IJPC archive by keyword, topic, or issue at:
https://ijpc.com/Products